GRAIL, Inc. (GRAL) stock
GRALNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$105.88+0.28 (+0.27%)
Close on Nov 17, 2026Market cap $4.73BP/E –Yield –
Grail cash
Cash and short-term investments held at the end of each period.
Grail's cash was $859.54M at Jun 30, 2026. For fiscal 2025 it was $901.94M, up 18.5% from the year before. The highest annual figure on record is $901.94M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $901.94M | +18.5% |
| FY2024 | Dec 31, 2024 | $761.38M | +682.6% |
| FY2023 | Dec 31, 2023 | $97.29M | -60.5% |
| FY2022 | Jan 1, 2023 | $246.13M | +8.9% |
| FY2021 | Jan 3, 2022 | $225.99M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $859.54M | +43.1% |
| Q1 FY2026 | Mar 31, 2026 | $820.31M | +22.0% |
| Q4 FY2025 | Dec 31, 2025 | $901.94M | +18.5% |
| Q3 FY2025 | Sep 30, 2025 | $538.17M | -36.9% |
| Q2 FY2025 | Jun 30, 2025 | $600.62M | -37.4% |
| Q1 FY2025 | Mar 31, 2025 | $672.60M | +236.8% |
| Q4 FY2024 | Dec 31, 2024 | $761.38M | +682.6% |
| Q3 FY2024 | Sep 30, 2024 | $853.55M | +493.4% |
| Q2 FY2024 | Jun 30, 2024 | $958.85M | +315.8% |
| Q1 FY2024 | Mar 31, 2024 | $199.72M | -18.9% |
| Q4 FY2023 | Dec 31, 2023 | $97.29M | -57.0% |
| Q3 FY2023 | Oct 1, 2023 | $143.84M | – |
| Q2 FY2023 | Jun 30, 2023 | $230.62M | – |
| Q4 FY2022 | Jan 1, 2023 | $246.13M | – |
| Q4 FY2021 | Jan 3, 2022 | $225.99M | – |
See a number that looks wrong?